Efficacy of cocktail analgesic injection to the joint capsule for pain management after total hip arthroplasty

Not Applicable

Recruiting

• Conditions: osteoarthritis

• Registration Number: JPRN-UMIN000042302
• Lead Sponsor: Kyushu Universit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-11-02
• Study Completion: 2022-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who are difficult to administer lumbar anesthesia 2) Patients requiring total resection of the articular capsule (cases of high dislocation and cases with femoral osteotomy) 3) Patients with poorly controlled diabetic comorbidities and susceptible conditions. 4) Patients with neurological and muscular diseases of the affected limb (e.g., Charcot's joints) 5) Patients with comorbid conditions that may affect consent or assessment, such as dementia, schizophrenia, depression, panic disorder, and generalized anxiety disorder. 6) Patients with a history of allergy to the drugs used in this study. 7) Patients deemed to require lower extremity surgery, including total hip or total knee replacement, within 6 months of participation in this study. 8) Patients who had lower extremity surgery, such as total hip, knee, or osteotomy, in less than 6 months prior to participation in this study. Translated with www.DeepL.com/Translator (free version)

Study & Design

• Study Type: Interventional
• Study Design: Not specified